First synthesis and biological evaluation of 4-amino-2-aryl-6,9-dichlorobenzo[g]pteridines as inhibitors of TNF-α and IL-6.
暂无分享,去创建一个
A. Guirado | P. García-Peñarrubia | D. Bautista | A. J. Ruiz-Alcaraz | J. Gálvez | J. I. López Sánchez
[1] A. Guirado,et al. Synthesis and biological evaluation of 4-alkoxy-6,9-dichloro[1,2,4]triazolo[4,3-a]quinoxalines as inhibitors of TNF-α and IL-6. , 2012, European journal of medicinal chemistry.
[2] L. Kőhidai,et al. GnRH-III based multifunctional drug delivery systems containing daunorubicin and methotrexate. , 2012, European journal of medicinal chemistry.
[3] Thommey P. Thomas,et al. Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting. , 2012, European journal of medicinal chemistry.
[4] A. Gulevskaya,et al. Synthesis of pteridines fused to heterocycles , 2011 .
[5] P. Zapater,et al. Peritoneal macrophage priming in cirrhosis is related to ERK phosphorylation and IL‐6 secretion , 2011, European journal of clinical investigation.
[6] A. Guirado,et al. A new and efficient synthetic approach to dichlorofluoflavines. Study of the stability of isomeric fluoflavines by HF and B3LYP procedures , 2009 .
[7] Fu-xiang Ran,et al. Novel 8-deaza-5,6,7,8-tetrahydroaminopterin derivatives as dihydrofolate inhibitor: design, synthesis and antifolate activity. , 2009, European journal of medicinal chemistry.
[8] P. Tak,et al. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. , 2008, Pharmacology & therapeutics.
[9] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.
[10] S. Matsika,et al. 6MAP, a fluorescent adenine analogue, is a probe of base flipping by DNA photolyase. , 2007, The journal of physical chemistry. B.
[11] G. Noronha,et al. Discovery of 3,3'-(2,4-diaminopteridine-6,7-diyl)diphenol as an isozyme-selective inhibitor of PI3K for the treatment of ischemia reperfusion injury associated with myocardial infarction. , 2007, Journal of medicinal chemistry.
[12] O. Lenz,et al. Evaluation of the anti-hepatitis C virus effect of novel potent, selective, and orally bioavailable JNK and VEGFR kinase inhibitors. , 2007, Bioorganic & medicinal chemistry letters.
[13] P. Rutgeerts,et al. Immunosuppressive activity of a new pteridine derivative (4AZA1378) alleviates severity of TNBS-induced colitis in mice. , 2007, Clinical immunology.
[14] Evaldas Katilius,et al. Signaling aptamers created using fluorescent nucleotide analogues. , 2006, Analytical chemistry.
[15] D. Furst,et al. Problems encountered during anti-tumour necrosis factor therapy. , 2006, Best practice & research. Clinical rheumatology.
[16] Z. Hou,et al. The two-photon excitation cross section of 6MAP, a fluorescent adenine analogue. , 2005, The journal of physical chemistry. B.
[17] J. Wu,et al. Parallel synthesis of pteridine derivatives as potent inhibitors for hepatitis C virus NS5B RNA-dependent RNA polymerase. , 2005, Bioorganic & medicinal chemistry letters.
[18] D. Furst. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis. , 2004, Clinical therapeutics.
[19] J. Smolen,et al. Therapeutic strategies for rheumatoid arthritis , 2003, Nature Reviews Drug Discovery.
[20] G. Wenska,et al. Synthesis and Fluorescence Quenching Study of the Novel Cationic Probe Derived from Luminarosine , 2001 .
[21] I. Enyedy,et al. Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening. , 2001, Journal of medicinal chemistry.
[22] M. Williams,et al. Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitor.. , 2001, Journal of medicinal chemistry.
[23] M. Feldmann,et al. The role of TNF alpha and IL-1 in rheumatoid arthritis. , 2001, Current directions in autoimmunity.
[24] W. Pfleiderer,et al. A new, general and regioselective method for the synthesis of 2,6-disubstituted 4-aminopteridines , 1997 .
[25] A. Guirado,et al. One-Pot Synthesis of 1,4-Dichlorophenazines , 1997 .
[26] Alan R. Katritzky,et al. Comprehensive Heterocyclic Chemistry IV , 1996 .
[27] C. Temple,et al. Antimitotic agents: ring analogues and derivatives of ethyl [(S)-5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7- yl]carbamate. , 1992, Journal of medicinal chemistry.
[28] S. Kerwar,et al. Biochemical and biological studies on 2-desamino-2-methylaminopterin, an antifolate the polyglutamates of which are more potent than the monoglutamate against three key enzymes of folate metabolism. , 1992, Cancer research.
[29] J. Paquet,et al. Reactions of polar dienes with o-quinones , 1989 .
[30] R. Moran,et al. The 2-desamino and 2-desamino-2-methyl analogues of aminopterin do not inhibit dihydrofolate reductase but are potently toxic to tumor cells in culture. , 1989, Journal of medicinal chemistry.
[31] H. Iwamura,et al. Effects of 4-alkylaminopteridines on tobacco callus growth , 1980 .
[32] E. Taylor,et al. Pteridines. XXXIX. Synthesis of 2,4-diamino-7-alkenylpteridines and their 8-oxides , 1976 .
[33] S. Patai,et al. The Chemistry of the quinonoid compounds , 1974 .
[34] K. Ota,et al. Pteridine studies. XLI. New routes to 4-aminopteridines via 3-(dimethylaminomethyleneamino)pyrazine-2-carbonitrile and related compounds. , 1971, Journal of the Chemical Society. Perkin transactions 1.
[35] A. J. Villani,et al. Pteridines. XI. Pteridines related to the diuretic, 2,4-diamino-6,7-dimethylpteridine , 1968 .
[36] R. C. Elderfield. Pteridines, alloxazines and compounds with 7-membered or larger rings , 1967 .
[37] A. J. Villani,et al. Pteridines. III. Synthesis of Some Ketones, Carbinols, and N-Oxides , 1963 .
[38] I. J. Pachter,et al. Pteridines. I. Synthesis of Some 6-Alkyl-7-aminopteridines from Nitrosopyrimidines , 1963 .
[39] T. Bardos,et al. Synthesis of Deoxyalloxazines (Benzopteridines)1 , 1957 .
[40] A. Albert,et al. 886. Pteridine studies. Part X. Pteridines with more than one hydroxy- or amino-group , 1956 .
[41] A. Albert. Pteridine studies. Part VII. The degradation of 4-, 6-, and 7-hydroxypteridine by acid and alkali , 1955 .
[42] W. Jones,et al. 21. Pteridines. Part I. An unambiguous synthesis of 7 : 8-dihydro-6-hydroxypteridines , 1951 .
[43] G. M. Timmis. A New Synthesis of Pteridines , 1949, Nature.
[44] M. Gates. The chemistry of the pteridines. , 1947, Chemical reviews.
[45] Oskar Isay. Eine Synthese des Purins , 1906 .
[46] S. Gabriel,et al. Synthesen in der Purinreihe , 1901 .